iMed Technologies Investors

iMed Technologies is developing AI technology based assisting tool for surgical operations of treatment of brain infarction and subarachnoid hemorrhage. Utilizing the state-of-the art AI learning technology and plenty of medical data, iMed Technology develops a real-time assisting product for physicians who engage in surgical operations for brain infarction and/or subarachnoid hemorrhage patients with the mission of providing safer medical services.
Industry:
Other
Investor Type:
Healthcare Company
Headquarters:
Tokyo, Tokyo, Japan
Founded Date:
2019